IQVIA

Biostatisticien Senior FSP, Phase Tardive (Senior Biostatistician)

Kirkland, Quebec, Canada

Not SpecifiedCompensation
Junior (1 to 2 years)Experience Level
Full TimeJob Type
UnknownVisa
Pharmaceuticals, BiotechnologyIndustries

Requirements

Candidates should possess a Bachelor's degree in Biostatistics, Statistics, Mathematics, or a related field, and hold a Master's degree is preferred. They should have at least 7 years of experience in biostatistical analysis, particularly within clinical trials, with a strong understanding of statistical methods and SAS or R programming. Experience with Phase 2/3 drug development is highly desirable.

Responsibilities

The Senior Biostatistician will collaborate with multidisciplinary project teams to establish project timelines, provide statistical data for studying clinical trial summaries and protocols, and draft or revise statistical sections of clinical trial protocols, consulting with internal and external experts. They will also draft or revise statistical analysis plans, datasets, and TLF specifications, offer guidance and supervision to programmers in developing analysis datasets and programming tables, lists, and figures, manage internal and CRO project activities, and support exploratory analyses and publications, contributing to clinical study reports and regulatory documents such as DSURs.

Skills

Biostatistics
SAS
R
Clinical trial protocols
Data analysis plans
Statistical analysis
Data management
Regulatory documentation

IQVIA

Advanced analytics and clinical research services

About IQVIA

IQVIA provides advanced analytics, technology solutions, and clinical research services specifically for the life sciences industry. Their services utilize extensive data resources and technology to create connections within healthcare, allowing clients to gain insights that help speed up the development and marketing of new medical treatments. This process is facilitated by their IQVIA Connected Intelligence™ system, which offers quick and flexible insights. IQVIA stands out from competitors by focusing on patient privacy, employing various technologies to protect individual data. The company's goal is to enhance healthcare outcomes by supporting biotech, pharmaceutical, and medical device companies, as well as researchers and government agencies, in understanding diseases and advancing medical science.

Key Metrics

Durham, North CarolinaHeadquarters
1998Year Founded
$3,526MTotal Funding
POST_IPO_EQUITYCompany Stage
Cybersecurity, Biotechnology, HealthcareIndustries
10,001+Employees

Risks

Rapid advancement of cancer vaccines may disrupt traditional clinical research models.
Proliferation of disparate technological solutions causes technology overload in clinical trials.
Generative AI technologies face challenges in adoption due to data privacy concerns.

Differentiation

IQVIA leverages advanced analytics and big data for life sciences solutions.
The company offers privacy-enhancing technologies to protect individual patient data.
IQVIA's AI Assistant provides rapid, actionable insights for healthcare and life sciences.

Upsides

Increased adoption of decentralized clinical trials enhances patient-centric study designs.
AI-driven drug discovery accelerates identification of potential drug candidates.
Expansion of telemedicine facilitates remote patient monitoring and data collection.

Land your dream remote job 3x faster with AI